HIV Medications for HIV Prevention: News & Research
- Report of a Consultation: Preparing for Pre-Exposure Prophylaxis (PrEP) Results: From Research to Implementation (PDF) (2010)
Meeting was held at the Hotel Victoria-Glion, 29-30 October 2009.
From World Health Organization
- U.S. Health Officials Announce Shift in Focus of PrEP Trial in Botswana (December 18, 2009)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Questions and Answers: The VOICE HIV Prevention Study (September 16, 2009)
From U.S. National Institute of Allergy and Infectious Diseases
- Clinical Trial of Antiretroviral-Based HIV Prevention Strategies for Women Now Under Way (September 16, 2009)
From U.S. National Institute of Allergy and Infectious Diseases
- Maraviroc Levels in Female Genital Tract May Support Drug's Potential in HIV Prophylaxis (August 2009)
In Journal of Acquired Immune Deficiency Syndromes
- Prepping for a PrEP Trial (July/August 2009)
Why is it so hard to find young people to participate in HIV-related studies? While trying to find an assistant to help recruit young, gay men for a trial of pre-exposure HIV prophylaxis (PrEP), HIV advocate Keith Green may have stumbled on an answer: homophobia.
To read PDF, click here.
In Positively Aware, from Test Positive Aware Network
- Low Bone Mineral Density in Botswana PrEP Trial Participants Raises Concerns (July 24, 2009)
Researchers conducting a trial of tenofovir and emtricitabine as pre-exposure prophylaxis (PrEP) in Botswana have found low bone mineral density levels in HIV-uninfected volunteers at enrollment.
From aidsmap.com
- Antiretrovirals Can Be Used to Prevent Spread of HIV/AIDS, Model Shows (July 21, 2009)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- The Promise of Pre-Exposure Prophylaxis (June 1, 2009)
To read PDF, click here.
In GMHC Treatment Issues, from Gay Men's Health Crisis
- Herpes Drug Acyclovir Does Not Reduce Risk of HIV Transmission, Does Slow HIV Progression, Study Says (May 14, 2009)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Could Isentress (or Other Integrase Inhibitors) Be Used as an HIV Prevention Drug? (April 28, 2009)
From aidsmap.com
- Inter Press Service Examines Research Into PrEP (April 6, 2009)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Interview With Myron Cohen, M.D. (March 2009)
To read PDF, click here.
In GMHC Treatment Issues, from Gay Men's Health Crisis
- Pre-Exposure Prophylaxis (Winter/Spring 2009)
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
- HIV Pre-Exposure Prophylaxis in the United States: Impact on Lifetime Infection Risk, Clinical Outcomes and Cost-Effectiveness (February 26, 2009)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Intermittent Oral PrEP May Be as Effective as Daily Oral PrEP for Prevention of Rectal HIV Transmission, Macaque Study Suggests (February 9, 2009)
Gerardo Garcia-Lerma, Ph.D., presents data from a macaque study utilizing a unique method of pre-exposure prophylaxis: oral tenofovir/emtricitabine administered just once prior to exposure, followed by a second dose shortly after exposure.
In The 16th Conference on Retroviruses and Opportunistic Infections, from TheBodyPRO.com
- Topical PrEP Comparison: Tenofovir Alone May Be as Effective as Tenofovir/FTC, Study Finds (February 9, 2009)
Walid Heneine, Ph.D., explains the results of a study in macaques which found that a topical gel offered complete protection against SIV infection -- regardless of whether that gel contained tenofovir alone or tenofovir in combination with emtricitabine.
In The 16th Conference on Retroviruses and Opportunistic Infections, from TheBodyPRO.com
- ABC News Examines Pre-Exposure Prophylaxis for HIV Prevention (January 22, 2009)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- For Post-Exposure HIV Prevention, Viread May Be Gentler Option than Retrovir (April 17, 2008)
From Reuters Health
- New Frontiers in HIV Prevention: Male Circumcision and Pre-Exposure Prophylaxis in the United States -- An Interview at CROI 2007 With Patrick Sullivan, Ph.D., and Lynn Paxton, M.D., M.P.H. (February 27, 2007)
In Exclusive Coverage of the 14th Conference on Retroviruses and Opportunistic Infections, from TheBodyPRO.com
- HIV Clinical Trial Aiming to Increase Participation of Black MSM (January 11, 2007)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
|
Advertisement
|
Email
Glossary
